2022
DOI: 10.1016/j.clim.2022.109092
|View full text |Cite
|
Sign up to set email alerts
|

Decrease in CD8+CD45+CCR7+CD62L+ T cells in individuals vaccinated with Sinovac-CoronaVac following COVID-19 infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 11 publications
(10 reference statements)
0
2
0
Order By: Relevance
“…Regarding immunity, a two-dose regimen of SV can produce B cell and CD4 T cell activation in addition to eliciting the production of notable levels of anti-RBD antibodies able to neutralize the SARS-CoV-2 variants of concern. After SV administration, helper T lymphocyte numbers are augmented, Th2 profiles are prevalent, and increased Treg cells are also found. Three months after the second SV dose, the number of central and effector memory CD4 + and CD8 + T cells as well as serum antibody levels decreased significantly. , However, remarkable amounts of IFN-γ- and granzyme B-producing cells are detected at 28 and 90 days postvaccination …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Regarding immunity, a two-dose regimen of SV can produce B cell and CD4 T cell activation in addition to eliciting the production of notable levels of anti-RBD antibodies able to neutralize the SARS-CoV-2 variants of concern. After SV administration, helper T lymphocyte numbers are augmented, Th2 profiles are prevalent, and increased Treg cells are also found. Three months after the second SV dose, the number of central and effector memory CD4 + and CD8 + T cells as well as serum antibody levels decreased significantly. , However, remarkable amounts of IFN-γ- and granzyme B-producing cells are detected at 28 and 90 days postvaccination …”
Section: Discussionmentioning
confidence: 99%
“…Three months after the second SV dose, the number of central and effector memory CD4 + and CD8 + T cells as well as serum antibody levels decreased significantly. 31,32 However, remarkable amounts of IFN-γ-and granzyme B-producing cells are detected at 28 and 90 days postvaccination. 33 Zhou and collaborators reported that one year after natural infection, the levels of IgG antibodies returned to the baseline and increased (3.9-fold) after immunization with inactivated vaccine and reached levels similar to those in the early stage of recovery; however, the IgA or IgM response failed to produce the same effect, suggesting that IgG is the main antibody for long-term protection.…”
Section: ■ Discussionmentioning
confidence: 99%